Generate Biomedicines, Inc. (GENB) Net Margin
- 2026-06-30: Net Margin -1065.17%.
- 2026-03-31: Net Margin -850.58%.
- 2025-06-30: Net Margin -517.56%.
- 2025-03-31: Net Margin -472.73%.
Complete source-backed net margin history.
- Available history
- 2025-03-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -1065.17% |
| 2026-03-31 | -850.58% |
| 2025-06-30 | -517.56% |
| 2025-03-31 | -472.73% |
Annual Net Margin
| Date | Net Margin |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |